mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
0.9 |